Koen van Beers, Sander Last, Pim Dekker, Erwin Birnie, Francisca van der Pluijm, Christine Fransman, Henk‐Jan Aanstoot, Max Nieuwdorp

 

Background: Diabetes care is under pressure, with increasing prevalence of people with diabetes (PWDs) and increasing staffing shortages. Also, many PWDs don’t reach glycemic targets. CloudCare, a care model using remote monitoring technology, combines remote monitoring with risk-stratified patient identification. In this analysis of a real-life cohort study we report the results after 12 months of follow-up.

Methods: We performed a cohort study with pre/post measurements and the CloudCare pathway as intervention. Included were adult PWDs diagnosed >6 months before inclusion. Outcomes were treatment satisfaction, number and type of contacts, diabetes-related distress and glucometrics.

Results: Currently 63 participants have 12-month follow-up data available, with a median age op 30.8 years (IQR 24.7-48.4) and a diabetes duration of 15 years (9-26). Most participants (87.3%) were on automated insulin delivery. Despite less face-to-face contacts per PWD per 3 months (baseline 0.82 vs. 12-months 0.39 [p<0.001]), treatment satisfaction remained high (mean DTSQ at baseline 30.18 [SD 3.86] vs. 12-months 30.38 [SD 4.10]; p0.96), adequate glycemic control was maintained (mean TIR at baseline 78.7 [SD 9.0] vs. 12-months 78.5% [SD 9.7], p=0.14), and diabetes-related distress decreased (PAID-5 at baseline 5.41 vs. 12-months 5.21, p=0.029). The type of contact shifted towards more electronic messaging (baseline 1.04 vs. 12-month 1.31 per PWD per 3 months).

Conclusion: Treatment satisfaction and glycemic control remained high after integrating CloudCare in our care pathway, while the number of face-to-face visits reduced. A randomised trial investigating CloudCare in both adults and children is currently being conducted.